Abstract. Interleukin (IL)-1 is a proinflammatory cytokine that plays important roles in inflammation and host responses to infection. The present study aimed to evaluate the effects of IL-1α on the apoptosis and differentiation of osteoblasts, and to elucidate the mechanism responsible for these effects in the osteoblast-like cell line MC3T3-E1. The MC3T3-E1 cells were non-treated or treated with IL-1α. Following treatment, cell viability, alkaline phosphatase (ALP) activity and caspase-3 activity were evaluated. The expression of osteoblast-specific genes as well as Bax, Bcl-2 and caspase-3 were determined by reverse transcription-quantitative polymerase chain reaction (RT-qPCR). The protein levels of Bax, Bcl-2, caspase-3 and the phosphorylation of mitogen-activated protein kinases (MAPKs, also known as MAP kinases) were evaluated using western blot analysis. The MAPK signaling pathway was blocked by pre-treatment with MAPK inhibitors SB203580, PD98059 and SP600125. IL-1α treatment induced a significant decrease in cell viability and ALP activity in the MC3T3-E1 cells. IL-1α also significantly decreased the mRNA expression and protein levels of osteoblast-related genes in the MC3T3-E1 cells. On the other hand, IL-1α significantly upregulated the mRNA expression and protein levels of Bax and caspase-3 as well as caspase-3 activity, whereas Bcl-2 expression was decreased in the MC3T3-E1 cells. Furthermore, IL-1α activated the apoptotic signaling pathway by increasing the phosphorylation of c-Jun N-terminal kinase (JNK) and p38-MAPK, whereas it inhibited the phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2). Moreover, pre-treatment with MAPK inhibitors attenuated the phosphorylation of JNK, p38 and Bax expression enhanced by IL-1α. However, MAPK inhibitors markedly increased the protein expression of osteoblast-related genes and Bcl-xL in the MC3T3-E1 cells downregulated by IL-1α. Taken together, these findings suggest that IL-1α induces the apoptosis of osteoblasts and inhibits osteoblast differentiation by activating the JNK and the p38 MAPK pathways.
Introduction
Bone is a dynamic tissue that constantly undergoes remodeling through a coupled process of bone formation by osteoblasts and resorption by osteoclasts throughout life (1) . Chronic osteomyelitis, a persistent infection of the bone, involves dysregulation of this process which results in excessive bone resorption (2) .
Interleukin (IL)-1 is a proinflammatory cytokine that plays important roles in inflammation and host responses to infection (3, 4) . Once released, IL-1 elicits a multitude of effects on target cells that lead to and modulate the inflammatory response as well as tissue damage (3) . The two forms of IL-1, IL-1α and IL-1β, have similar biological activities but different functional roles in the body (3, 5) . Bone is highly sensitive to IL-1, which is involved in the regulation of bone formation (6) (7) (8) and bone resorption (9) (10) (11) (12) .
Mitogen-activated protein kinases (MAPKs, also known as MAP kinases), including c-Jun N-terminal kinase (JNK) and p38, are involved in the progression of inflammatory responses and in the apoptosis of osteoblasts (13) (14) (15) . Moreover, the mechanism responsible for the effects of IL-1 on the differentiation and apoptosis of osteoblasts, which may occur through the MAPK signaling pathways, remains unclear. Thus, research into the effects of IL-1 on osteoblast differentiation and function as well as the subsequent development and evaluation of potential drugs suitable for preventing bone destruction in infective bone diseases remains an area of great interest.
The aim of the present study was to evaluate the mechanism responsible for the effects of IL-1α on the differentiation and apoptosis of osteoblasts. We also aimed to elucidate the mechanism through which IL-1α induces MAPK phosphorylation.
Materials and methods
Reagents. IL-1α was purchased from PeproTec (Rocky Hill, NJ, USA). 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), protease inhibitor cocktail, and the selective MAPK inhibitors SB203580, PD98059 and SP600125 were all purchased from Calbiochem (San Diego, CA, USA). 
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penicillin-streptomycin solution, 10 mM HEPES solution and incubated at 37˚C in a 5% CO 2 humidified atmosphere in air. To evaluate the effect of IL-1α on the differentiation and function of osteoblasts, the MC3T3-E1 cells at a density of 5x10 4 cells/cm 2 were cultured in osteogenic differentiation medium (DMEM with 10% FBS, 10 mM HEPES, 50 µg/ml L-ascorbic acid and 5 mM β-glycerophosphate (β-GP) for 2 days. On differentiation day 3, the cells were treated with 0.5, 1, 2.5, 5 and 10 ng/ml IL-1α or without IL-1α for the indicated times. To evaluate the effect of MAPK inhibitors on the phosphorylation of MAPKs in osteoblasts induced by IL-1α, MAPK inhibitors were applied for 2 h prior to IL-1α treatment.
Cell viability assay. Cell viability was measured using an MTT assay. The MC3T3-E1 cells (5x10 3 cells/well) were plated in 96-well culture plates in 0.2 ml culture medium and incubated overnight. To evaluate the effect of IL-1α on cell viability, the cells were treated with 0.5, 1, 2.5, 5 and 10 ng/ml IL-1α or without IL-1α for 1, 3 and 5 days. At the end of treatment, 20 µl MTT (5 mg/ml) was added to each well. The cells were cultured for an additional 4 h, the supernatant was removed, and then 100 µl dimethyl sulfoxide was added to each well. After shaking for 3 min, absorbance was measured at 490 nm using a microplate reader (Thermo MK3; Thermo Fisher Scientific Inc., Pittsburgh, PA, USA). The experiment was performed in triplicate.
Determination of ALP activity. The MC3T3-E1 cells were cultured in 100-mm diameter culture dishes in the presence or absence of IL-1α for 24 h. The supernatant was discarded and then subjected to the intracellular ALP enzyme assay as previously described (14) . Briefly, the cells were detached mechanically with a cell scraper in phosphate-buffered saline (PBS), and then centrifuged at 15,000 x g for 8 min. Cell pellets was placed in 300 µl of lysis buffer (Cytobuster protein extraction reagent; Novagen, Darmstadt, Germany) with 1X protease inhibitor cocktail. The ALP activity in the lysates was determined by the measurement of p-nitrophenyl phosphate (PNPP) using a commercial assay kit (Beyotime Institute of Biotechnology). The absorbance of the reaction mixture was measured by spectrophotometry (Eppendorf BioSpectrometer; Eppendorf AG, Hamburg, Germany) at 405 nm. Three replicates from each group were analyzed. Total protein concentrations were quantified by spectrophotometry (Eppendorf BioSpectrometer). ALP activity was normalized to the total protein in each sample.
Measurement of caspase-3 activity. The MC3T3-E1 cells were cultured in 100-mm-diameter culture dishes in the presence or absence of IL-1α for 24 h. The activity of caspase-3 was determined using the caspase-3 activity kit (Beyotime Institute of Biotechnology) according to the manufacturer's instructions, and then detected by spectrophotometry (Eppendorf BioSpectrometer). Briefly, the cells were detached with the aid of a cell scraper in PBS buffer, then centrifuged at 15,000 x g for 8 min and the cell pellets was placed in 300 µl of lysis buffer (Cytobuster protein extraction reagent) with 1X protease inhibitor cocktail. Total protein concentrations were quantified by spectrophotometry (Eppendorf BioSpectrometer). The samples were then incubated with a mixture provided in the kit, containing Ac-DEVD-pNA, the substrate of caspase-3. The optical density (coloration) resulting from the cleavage of the substrate and the release of pNA, was detected and quantified by spectrophotometry at 405 nm. A standard curve was also generated using a series of diluted pNA of known concentrations. The concentration was calculated by projecting the optical densities on the standard curve. All the experiments were performed in triplicate.
Analysis of the apoptosis of osteoblasts.
To measure apoptosis, we performed Hoechst 33258 staining (Beyotime Institute of Biotechnology) to visualize nuclear morphology and nucleosomal DNA fragmentation in osteoblasts. The MC3T3-E1 cells (4x10 4 cells/cm 2 ) were seeded into 12-well plates and incubated overnight prior to the experiment. The cells were treated with 0.5, 1, 2.5, 5 and 10 ng/ml IL-1α or without IL-1α for 1 day. At the end of the treatment, the cells were washed to remove non-adherent cells, and the adherent cells were fixed in 4% paraformaldehyde solution for 10 min. After washing with PBS, the cells were incubated with 0.2 mM Hoechst 33258 for 5 min in the dark. The cells with nuclei containing clearly condensed chromatin or the cells with fragmented nuclei were scored as apoptotic; the results were expressed as the number of apoptotic cells. The images of apoptotic osteoblasts were captured with a fluorescence microscope (Olympus IX71; Olympus Optical, Tokyo, Japan).
RNA isolation and reverse transcription-quantitative polymerase chain reaction (RT-qPCR).
Total RNA was isolated using TRIzol reagent (Invitrogen, Grand Island, NY, USA) and quantified by spectrophotometry. After isolation, 2 µg total RNA from each sample was reverse transcribed utilizing the HiFi-MMLV cDNA kit (Beijing CoWin Biotech Co., Ltd., Beijing, China) according to the manufacturer's instructions. The primer sequences of the osteoblast-associated genes, caspase-3, Bax and β-actin (Generay Biotech Co., Ltd., Shanghai, China) and annealing temperatures used in this study are listed in Table I . qPCR was performed with SYBR ® Premix Ex Taq™ (Takara, Dalian, China) according to the manufacturer's instructions. All qPCR reactions were performed using the ABI 7300 sequence detection system (Applied Biosystems, Grand Island, NY, USA). In each reaction, 1 µl cDNA, 10 µl SYBR ® Premix Ex Taq (Takara), and 0.4 µM forward and reverse primer in a total volume of 20 µl were used. The reaction conditions were as follows: 1 cycle of 95˚C for 30 sec followed by 40 cycles of 95˚C for 5 sec and 60-66˚C for 30 sec. qPCR assays were run in triplicate for each sample. β-actin was used as the internal control, and all results were analyzed using the standard 2 -ΔΔCT method as described previously (16) .
Western blot analysis. At the end of treatment, the cell culture medium was aspirated and the cells were detached in PBS by scraping. The detached cells were centrifuged at 15,000 x g at 4˚C for 8 min. Cell pellets were lysed in 300 µl lysis buffer (Cytobuster protein extraction reagent) with 25 mM NaF, 1 mM Na 3 VO 4 , and 1X protease inhibitor cocktail. Protein concentrations were quantified by spectrophotometry (Eppendorf BioSpectrometer). For the western blot analysis, equal amounts of protein from each sample were separated by SDS-PAGE and electrotransferred onto PVDF membranes (Millipore, Bedford, MA, USA). The membranes were then blocked with 5% (w/v) bovine serum albumin in TBST [10 mM Tris, 150 mM NaCl, and 0.1% (v/v) Tween-20, pH 7.5] for 1 h at room temperature, and incubated with primary antibodies: rabbit polyclonal anti-JNK, p-JNK, β-actin, capase-3, Bax, mouse polyclonal anti-OSX, ALP, OCN, Runx2 and cytochrome c at dilutions of 1:300 (all from Santa Cruz Biotechnology, Inc.); rabbit polyclonal anti-ERK1/2, p-ERK1/2, p38, p-p38, Bcl-2 and Bcl-xL at dilutions of 1:800 (Cell Signaling Technology, Inc.). The secondary antibodies used for detection were horseradish peroxidase (HRP)-conjugated goat anti-rabbit immunoglobulin G (IgG) and HRP-conjugated goat anti-mouse IgG (both from Santa Cruz Biotechnology, Inc.). Enhanced chemiluminescence (ECL; Beijing CoWin Biotech Co., Ltd.) was performed in order to detect immunoreactive protein signals.
Protein signals were visualized and images were captured with a chemiluminescence detection system (MiniChemi™ III; Beijing Sage Creation Science Co., Ltd., Beijing, China) and quantified using ImageJ software (National Institutes of Health, Bethesda, MD, USA). For re-probing, the PVDF membranes were stripped with 0.2 M NaOH for 15 min prior to blocking with another primary antibody. The expression of molecules of interest was determined relative to β-actin.
Statistical analysis. The data are expressed as the means ± standard deviation (SD) for three or more independent experiments. Significant differences were determined using factorial analysis of variance (ANOVA). Statistical analysis was performed using SPSS 13.0 software. A P-value <0.05 was considered to indicate a statistically significant difference.
Results

Effect of IL-1α on the viability of MC3T3-E1 cells.
The MC3T3-E1 cells were treated with IL-1α at concentrations of 0.5, 1, 2.5, 5 and 10 ng/ml or without IL-1α for 1, 3 and 5 days. MTT assays showed that the viability of the MC3T3-E1 cells exposed to IL-1α was significantly reduced compared with that in the non-treated culture at 1, 3 and 5 days (P<0.01) (Fig. 1A) .
Effect of IL-1α on ALP activity in MC3T3-E1 cells.
The MC3T3-E1 cells were treated with IL-1α at concentrations of 0.5, 1, 2.5, 5 and 10 ng/ml or without IL-1α for 24 h. The ALP activity in the MC3T3-E1 cells exposed to IL-1 was significantly decreased in a dose-dependent manner compared with that in the non-treated culture at 1 day (P<0.01) (Fig. 1B) .
Effect of IL-1α on caspase-3 activity in MC3T3-E1 cells.
To evaluate IL-1α-induced caspase-3 activity, the MC3T3-E1 cells were treated with IL-1α at concentrations of 0.5, 1, 2.5, 5 and 10 ng/ml or without IL-1α for 24 h. IL-1α significantly increased caspase-3 activity in a dose-dependent manner compared with that in the non-treated culture at 24 h (P<0.01) (Fig. 2A) .
Effect of IL-1α on the mRNA and protein expression of Bax, Bcl-2 and caspase-3 in MC3T3-E1 cells. The MC3T3-E1
cells were treated with IL-1α at concentrations of 0.5, 1, 2.5, 5 and 10 ng/ml or without IL-1α for 24 h. IL-1 significantly increased the mRNA expression and the protein levels of Bax and caspase-3 in a dose-dependent manner compared with that in the non-treated culture at 24 h (P<0.01), whereas Bcl-2 expression was decreased (P<0.01) in the MC3T3-E1 cells (Figs. 2B and 3 ). Following treatment with IL-1α at 5 ng/ml for 24 h, IL-1α significantly increased the protein expression of Bax, cytochrome c and caspase-3 in a time-dependent manner compared with that in the non-treated culture, whereas Bcl-2 expression was unaffected (Fig. 4) . osteoblasts was increased by IL-1α treatment in a dose-dependent manner compared with that in the non-IL-1α-treated group at 24 h (Fig. 5) . cells were treated with IL-1α at concentrations of 0.5, 1, 2.5, 5 and 10 ng/ml or without IL-1α for 24 or 48h. IL-1 significantly decreased the mRNA expression and the protein levels of the osteoblast-specific genes Runx2, ALP, OSX and OCN in the MC3T3-E1 cells in a dose-dependent manner compared with those in the non-treated culture at 24 h (P<0.01) (Figs. 6 and 7) . 
Effect of IL-1α on the mRNA and protein expression of osteoblast-specific genes in MC3T3-E1 cells. The MC3T3-E1
Effect of IL-1 on the activation of MAPK in MC3T3-E1 cells.
As MAP kinases are important regulators of inflammatory mediators and osteoblast differentiation, we performed western blot analysis to examine the effect of IL-1α on the activation of MAPKs in the MC3T3-E1 cells. The results showed that IL-1α at concentrations of 5 ng/ml significantly enhanced the protein levels of phosphorylated p38 MAPK, JNK1/2 and ERK1/2 at the 1 h incubation time (Fig. 8) ; moreover IL-1α at concentrations >5 ng/ml enhanced the protein levels of p-p38 MAPK and p-JNK1/2, whereas it markedly inhibited those of p-ERK1/2 (Fig. 9) .
As controls, the MAPK inhibitors SP600125, PD98059 and SB203580 were applied for 2 h prior to IL-1α treatment and then proteins were prepared at 1 or 24 h after IL-1α treatment in the presence of MAPK inhibitors. The results showed that pre-treatment with the MAPK inhibitors attenuated the phosphorylation of JNK and p38 MAPK induced by IL-1α; however, pre-treatment with the PD98059 (ERK inhibitor) resulted in the further inhibition of the phosphorylation of ERK1/2 induced by IL-1α (Fig. 10) . Moreover, pre-treatment with the MAPK inhibitors decreased the protein expression of Bax induced by IL-1α in the MC3T3-E1 cells. However, MAPK inhibitors markedly increased the protein expression of osteoblast-related genes and Bcl-xL in the MC3T3-E1 cells downregulated by IL-1α (Fig. 11) .
Discussion
Excessive bone resorption in chronic inflammatory diseases, such as septic arthritis, osteomyelitis and infected orthopedic implant failure, is at least partially caused by the activation of bacteria-induced inflammatory responses (2) . IL-1, a proinflammatory cytokine that is important in inflammation and host responses to infection, plays a well documented role in the modulation of osteoclastic bone resorption (10) (11) (12) and bone formation (6) (7) (8) (9) . However, the mechanism responsible for the effects of IL-1 on the differentiation and function of osteoblasts remains unclear. In the present study, IL-1α directly induced apoptosis and inhibited osteoblast differentiation of MC3T3-E1 osteoblasts. Our results confirmed that IL-1α inhibits osteoblast differentiation directly (6) (7) (8) (9) .
The inhibitory effect of IL-1α on osteoblast differentiation was confirmed by evaluating the expression of osteoblast marker genes. Runx2 (Cbfa1) is required for mesenchymal cell differentiation into preosteoblasts (17, 18) . OSX, downstream of Runx2, is an osteoblast-specific transcription factor essential for osteoblast differentiation and bone formation (19, 20) . ALP has been suggested to be involved in the early-stage molecular events of osteoblast differentiation, whereas OCN is involved in the late-stage molecular events (13, 21) . In the present study, the mRNA expression and protein levels of Runx2, ALP, OSX and OCN as well as ALP activity in MC3T3-E1 cells were significantly downregulated by IL-1α in a dose-dependent manner. Taken together, these findings indicate that the inhibitory effect of IL-1α on osteoblast differentiation may be due to the inhibition of osteoblast-related genes.
The induction of osteoblast apoptosis results in further bacteria-induced bone destruction (2). We evaluated the effect of IL-1α on inducing the apoptosis of MC3T3-E1 cells. Our data show that IL-1α significantly upregulated the expression of Bax, cytochrome c and caspase-3 as well as increasing caspase-3 activity, whereas Bcl-2 expression was decreased in the MC3T3-E1 cells. These results indicated that IL-1 induced osteoblast apoptosis in a dose-dependent manner compared with the non-treated cells. Moreover, IL-1α enhanced the protein levels of p-JNK and p-p38 MAPK in the MC3T3-E1 cells. Based on our results, we suggest that IL-1 induces the apoptosis of osteoblasts through a mitochondrial pathway.
MAP kinases are activated by various stresses, including proinflammatory cytokines, and affect apoptosis either positively or negatively (22, 23) . In many cell types, JNK and p38 MAPK contribute to the induction of apoptosis, whereas ERK inhibits apoptotic processes (23) (24) (25) (26) . In the present study, treatment with IL-1α enhanced the protein levels of p-p38 and p-JNK whereas it inhibited the phosphorylation of ERK. Pre-treatment with MAPK inhibitors attenuated the phosphorylation of JNK and p38 enhanced by IL-1α. Moreover, pre-treatment with MAPK inhibitors decreased the protein expression of Bax induced by IL-1α in the MC3T3-E1 cells. However, MAPK inhibitors markedly increased the protein expression of osteoblast-related genes and Bcl-xL in MC3T3-E1 cells downregulated by IL-1α. This suggests that the JNK and the p38 MAPK pathways play a vital role in regulating IL-1α-induced apoptosis and osteoblast differentiation of MC3T3-E1 cells.
In conclusion, our data suggest that IL-1α induces osteoblast apoptosis and inhibits bone formation by activating the JNK and the p38 MAPK pathways. These results indicate that agents modulating the JNK and the p38 MAPK pathways may be of potential therapeutic use for restoring osteoblast function in bacteria-induced bone diseases.
